Rifampicin D4

Rifampicin D4 is a deuterated form of the antibiotic drug Rifampicin. It is used as an analytical reference standard for laboratory research and analysis purposes. Rifampicin D4 is primarily used in the study of the pharmacokinetics and metabolic pathways of Rifampicin in the human body. Rifampicin is a broad-spectrum antibiotic that is primarily used in the treatment of bacterial infections, such as tuberculosis and leprosy. It works by inhibiting the RNA polymerase enzyme in bacteria, thereby preventing the synthesis of RNA and protein necessary for the survival and replication of the bacteria. Chemically, Rifampicin D4 is a derivative of Rifampicin that has four deuterium atoms substituted for four hydrogen atoms in its molecular structure. This modification does not alter the pharmacological properties of the drug, but it does provide a unique tool for researchers to track the metabolic fate of Rifampicin in the body. Rifampicin D4 is typically administered in laboratory experiments as a solution or in a powder form. It is important to handle Rifampicin D4 with care, following all appropriate safety precautions, as it is a potent antibiotic and can cause adverse effects if not used properly. In conclusion, Rifampicin D4 is a valuable analytical reference standard for researchers studying the pharmacokinetics and metabolic pathways of Rifampicin, a powerful antibiotic used to treat bacterial infections.